IL65493A - 2-(4-benzylpiperidino)-1-(4-halophenyl)-propan-1-ol derivatives,their preparation and pharmaceutical compositions containing them - Google Patents

2-(4-benzylpiperidino)-1-(4-halophenyl)-propan-1-ol derivatives,their preparation and pharmaceutical compositions containing them

Info

Publication number
IL65493A
IL65493A IL65493A IL6549382A IL65493A IL 65493 A IL65493 A IL 65493A IL 65493 A IL65493 A IL 65493A IL 6549382 A IL6549382 A IL 6549382A IL 65493 A IL65493 A IL 65493A
Authority
IL
Israel
Prior art keywords
derivatives
benzylpiperidino
halophenyl
propan
preparation
Prior art date
Application number
IL65493A
Other languages
English (en)
Other versions
IL65493A0 (en
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of IL65493A0 publication Critical patent/IL65493A0/xx
Publication of IL65493A publication Critical patent/IL65493A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Artificial Filaments (AREA)
  • Lubricants (AREA)
IL65493A 1981-04-14 1982-04-13 2-(4-benzylpiperidino)-1-(4-halophenyl)-propan-1-ol derivatives,their preparation and pharmaceutical compositions containing them IL65493A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8107445A FR2503705A1 (fr) 1981-04-14 1981-04-14 Derives de phenethanolamine, leur preparation et leur application en therapeutique

Publications (2)

Publication Number Publication Date
IL65493A0 IL65493A0 (en) 1982-07-30
IL65493A true IL65493A (en) 1985-03-31

Family

ID=9257367

Family Applications (1)

Application Number Title Priority Date Filing Date
IL65493A IL65493A (en) 1981-04-14 1982-04-13 2-(4-benzylpiperidino)-1-(4-halophenyl)-propan-1-ol derivatives,their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US4430334A (xx)
EP (1) EP0063084B1 (xx)
JP (1) JPS57179160A (xx)
AT (1) ATE9330T1 (xx)
AU (1) AU545216B2 (xx)
CA (1) CA1185604A (xx)
DE (1) DE3260703D1 (xx)
DK (1) DK154979C (xx)
ES (1) ES511365A0 (xx)
FI (1) FI821288L (xx)
FR (1) FR2503705A1 (xx)
GR (1) GR75543B (xx)
HU (1) HU186492B (xx)
IE (1) IE52877B1 (xx)
IL (1) IL65493A (xx)
MX (1) MX155561A (xx)
NO (1) NO821192L (xx)
NZ (1) NZ200275A (xx)
PT (1) PT74744B (xx)
ZA (1) ZA822489B (xx)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2534580A1 (fr) * 1982-10-13 1984-04-20 Synthelabo Derives de phenyl-1 piperidino-2 propanol, leur preparation, et medicaments qui les contiennent
FR2546166B1 (fr) * 1983-05-19 1985-10-25 Synthelabo Enantiomeres du erythro (benzyl-4 piperidino)-2 (hydroxy-4 ou benzyloxy-4 phenyl)-1 propanol, leur preparation et leur application en therapeutique
US4912117A (en) * 1985-07-02 1990-03-27 Merrell Dow Pharmaceuticals Inc. Novel chemical compounds
US4783471A (en) * 1985-07-02 1988-11-08 Merrell Dow Pharmaceuticals Inc. N-aralkyl piperidine methanol derivatives and the uses thereof
FR2672286B1 (fr) * 1991-01-31 1994-11-18 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(phenylmethyl)piperidin-1-yl]ethanol, leur preparation et leur application en therapeutique.
FR2678269B1 (fr) * 1991-06-27 1995-01-13 Synthelabo Derives de 1-(4-chlorophenyl)-2-[4-(2-phenylethyl)piperidin-1-yl]ethanol, leur application et leur preparation en therapeutique.
FR2696741B1 (fr) * 1992-10-12 1994-11-25 Synthelabo Dérivés de 1-(4-chlorophényl)-2-[4-[(4-fluorophényl)méthyl]piperidin-1-yl] éthanol, leur préparation et leur application en thérapeutique.
US20070048577A1 (en) * 2005-08-30 2007-03-01 The Government Of The United States Of America, As Represented By The Secretary Of The Navy Naval Re Scalable microbial fuel cell with fluidic and stacking capabilities

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (xx) * 1966-09-27 1968-01-22
DE1618010A1 (de) * 1967-06-15 1970-11-05 Thomae Gmbh Dr K Verfahren zur Herstellung von neuen Aminoketonen
IE34545B1 (en) * 1969-10-01 1975-06-11 Continental Pharma Amino-alcohols,their salts and process for preparing the same
AT354187B (de) * 1976-11-22 1979-12-27 Hoffmann La Roche Fungizides mittel

Also Published As

Publication number Publication date
JPS6124388B2 (xx) 1986-06-10
GR75543B (xx) 1984-07-27
FI821288A0 (fi) 1982-04-13
FI821288L (fi) 1982-10-15
IE52877B1 (en) 1988-03-30
HU186492B (en) 1985-08-28
NO821192L (no) 1982-10-15
DE3260703D1 (en) 1984-10-18
NZ200275A (en) 1984-07-06
ES8304548A1 (es) 1983-03-01
DK154979B (da) 1989-01-16
MX155561A (es) 1988-03-25
DK165282A (da) 1982-10-15
EP0063084B1 (fr) 1984-09-12
CA1185604A (en) 1985-04-16
PT74744A (fr) 1982-05-01
AU545216B2 (en) 1985-07-04
IE820869L (en) 1982-10-14
EP0063084A1 (fr) 1982-10-20
PT74744B (fr) 1985-01-08
ATE9330T1 (de) 1984-09-15
ES511365A0 (es) 1983-03-01
ZA822489B (en) 1983-02-23
FR2503705A1 (fr) 1982-10-15
IL65493A0 (en) 1982-07-30
FR2503705B1 (xx) 1983-11-04
JPS57179160A (en) 1982-11-04
US4430334A (en) 1984-02-07
DK154979C (da) 1989-07-10
AU8255582A (en) 1982-10-21

Similar Documents

Publication Publication Date Title
HUT41402A (en) Fungicide compositions containing azolyl-methyl-oxirane derivatives and process for preparing the active ingredients
ZA791732B (en) Carbazolyl-(4)-oxypropanolamine derivatives,preparation thereof and pharmaceutical compositions containing these compounds
ZA813555B (en) 2-(halogenomethyl-phenyl)-4-halogeno-oxazole derivatives,a process for the preparation thereof,and radiation-sensitive compositions containing these derivatives
IL76839A (en) Picoline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
IL50757A (en) 1-phenyl-2-(1,2,4-triazol-1-yl)-ethyl ether derivatives,their preparation and bactericidal and fungicidal compositions containing them
IL58299A (en) Fluorine-containing 1,4-dihydropyridine derivatives,their production and their medicinal use
DE2963145D1 (en) Fungicidal acylanilide compounds, their preparation, compositions containing them and their use
IL78691A (en) Quinolylglycinamide derivatives,their preparation and pharmaceutical compositions containing them
IL65493A (en) 2-(4-benzylpiperidino)-1-(4-halophenyl)-propan-1-ol derivatives,their preparation and pharmaceutical compositions containing them
DE3361757D1 (en) Salicylic-acid derivatives, process for their preparation, pharmaceutical preparations based on these compounds and their use
AU546629B2 (en) Acesulfam containing compositions
PH19471A (en) Oxindole derivatives and pharmaceutical composition containing them
HUT39147A (en) Process for preparing phenoxy-propanol-acethylene derivatives and pharmaceutical compositions containing such compounds
DE3064109D1 (en) Pseudotrisaccharides, their preparation and use as medicaments
ZA825428B (en) New imidazole compounds,process for the preparation thereof and pharmaceutical compositions containing them
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
IL66192A (en) Albomycin derivatives,their production and pharmaceutical compositions containing them
IL58806A0 (en) Fungicidal compositions comprising arylhydrazo-aldoximes and derivatives thereof,and certain such new compounds
IL56755A (en) Sex stimulant compositions comprising phenethylamine derivatives,certain such compounds and their preparation
SE8202254L (sv) 2,4-dioxacyklohexanon-derivat
NZ189846A (en) 1-/1-methylethylamino)-3-(4-alkylthio-1-naphthalenyloxy)-2-propanol pharmaceutical compositions
IE821627L (en) MICRONIZED 2-(4-CHLOROPHENYL)-s-TRIAZOLO¹£5,1-a|-ISOQUINOLINE ANTIFERTILITY FORMULATION